Abstract: An article may include a material having a surface containing at least one zinc oxide and/or salt, and at least one antioxidant. A method of using a mixture including at least one zinc oxide and/or salt, and at least one antioxidant, as bacteriostatic agent may include: applying the mixture to a surface of an article.

Abstract: An article may include a material having a surface containing at least one zinc oxide and/or salt, and at least one antioxidant. A method of using a mixture including at least one zinc oxide and/or salt, and at least one antioxidant, as bacteriostatic agent may include: applying the mixture to a surface of an article.

Abstract: An implantable medical device may include a coating layer that includes a nanostructured hydroxyapatite doped with zinc ions and functionalized with lactoferrin. A process for coating an implantable medical device may include: providing an electrolytic bath; immersing a cathode and an anode in the electrolytic bath, the cathode including the implantable medical device; and allowing direct electric current to pass through the electrolytic bath so as to obtain electrolytic deposition on the implantable medical device of nanostructured hydroxyapatite doped with zinc ions. The electrolytic bath may include calcium ions, phosphate ions, and the zinc ions. The electrolytic bath also may include lactoferrin. The process may further include depositing lactoferrin on the implantable medical device coated with the nanostructured hydroxyapatite doped with the zinc ions.

Abstract: A composition, comprising: at least one polyhydroxyalkanoate (PHA); and at least one calcium phosphate. The at least one calcium phosphate is in a form of aggregates having an average size greater than or equal to 0.1 micron (?m) and less than or equal to 10 ?m.